Bryant_Lab @LabBryant

Professor of Urology, Academic Consultant Urologist, Prostate Cancer Research. prior CRUK/RCSEng Clinician Scientist Fellow. RT not endorsement. views my own. nds.ox.ac.uk/team/richard-b… Oxford, England Joined May 2018

Tweets

284
Followers

323
Following

237
Likes

909

Bryant_Lab @LabBryant

a week ago

Great to see so many site PIs and research nurses and team members at the @PART_Trial Investigators Meeting. Full RCT of #focaltherapy for T2 GGG2-3 #prostatecancer across the UK @SITU_Oxford @NDSurgicalSci - onwards and upwards!!

PART_Trial @PART_Trial

2 weeks ago

Thanks to everyone that was able to join us for our @PART_Trial Investigator's meeting on Friday 5th June and congratulations to our award winners!🏆👏😊@LabBryant @SITU_Oxford @OCTRUctu @NDSurgicalSci @OUHospitals @NHS_Lothian @FrimleyHealth

0 4 6 446 0

0 1 3 227 0

View Details

Bryant_Lab @LabBryant

a week ago

Nice interview. We are doing a full scale RCT of #focaltherapy for #prostate cancer (T2, GGG2-3) across the UK - @PART_Trial is recruiting @SITU_Oxford @treatyOfSharma @marclaniado @tomleslie21 @IP_London

Adam B. Weiner, MD @Adam_Weiner535

3 weeks ago

🚨Focal therapy for #prostatecancer🚨 ❔Who is the ideal candidate for trials to investigate? 🎙️@LondonProstate1 weighs in on this episode of the #UroOncMinute live from #EAU26 @Uroweb @IP_London @UrologyTimes 🔗shorturl.at/vpMaY

0 5 8 6K 1

1 2 11 2K 0

View Details

PART_Trial @PART_Trial

2 weeks ago

0 4 6 446 0

View Details

Bryant_Lab @LabBryant

2 months ago

Grateful to @BJUIjournal for publishing “The PRAGMATIC pathway ‐ PRostate cancer diAGnosis and MAnagement Triage In Clinical care”. Effective triaging steps for the highest risk suspected prostate cancer patients for rapid diagnosis & treatment bjui-journals.onlinelibrary.wiley.com/doi/epdf/10.11…

0 1 3 126 0

View Details

Bryant_Lab @LabBryant

3 months ago

@PART_Trial momentum. Grateful to all patients, & @NIHRresearch @NDSurgicalSci @SITU_Oxford & recruiting at Oxford, Edinburgh, Wexham Park, Reading, Coventry, Leeds, London (Imperial, UCL, Bart’s). Partial Ablation Vs Radical Tx for prostate cancer. @LondonProstate1 @mrsprostate

PART_Trial @PART_Trial

3 months ago

Thanks to @RBNHSFT for recruiting our 153rd participant to @PART_Trial we are 'halfway there' ‼️🥳also a HUGE thanks to all our PART sites, teams and participants 👏😊Let's keep going 💪#PAvsRT @LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

0 0 8 507 1

0 2 4 359 0

View Details

Bryant_Lab @LabBryant

7 months ago

@LondonProstate1 @IP_London @bostonsci @SonablateCorp @mrsprostate @SGuillaumier @lucysimmons1 @johannboaz @FocalSociety @UkFocal @UKFUSFoundation @prost8uk @ProstateUKProfs The @NIHRresearch funded @PART_trial is robustly evaluating #focal therapy versus standard treatment options, recruiting in several UK centres not shown here. Level 1 evidence needed. @NDSurgicalSci @angiodynamics @FocalOneHIFU @SITU_Oxford

0 2 4 446 0

View Details

Nuffield Department of Surgical Sciences @NDSurgicalSci

7 months ago

A ground-breaking new study will test how artificial intelligence can make prostate cancer diagnosis more accurate. The study by the University of Oxford is funded by a £1.9m grant from research charity Prostate Cancer UK. Read more ➡️ nds.ox.ac.uk/news/new-ai-to…

0 2 3 885 1

View Details

Bryant_Lab @LabBryant

8 months ago

@VincentGnanapr3 @pash22 @ponganer @AlwynDart @LondonProstate1 @susan_bewley @MichaelBaum11 @naserturabi @mgtmccartney Other problems that need urgent focus are high rates of presentation with advanced disease, and health disparity, for Black & low socioeconomic & older men, varied access to molecular staging, & variable Active Surveillance. Screening risks of over-detection and over-treatment

0 0 1 57 0

View Details

Bryant_Lab @LabBryant

8 months ago

Tremendous effort @MarkarSheraz @SITU_Oxford @NDSurgicalSci @OCTRUctu !!! 👏

SARONG OG @SARONG_Trial

8 months ago

🎉SARONG just hit 800 participants! A huge THANK YOU to all the incredible research teams and especially to our amazing participants. We are so grateful for your support! #ResearchMilestone #ThankYou @MarkarSheraz @SITU_Oxford @OCTRUctu @NDSurgicalSci

0 0 7 2K 0

0 2 4 418 1

View Details

Bryant_Lab @LabBryant

8 months ago

@Reddy4Urology presenting results of a multicentre evaluation of infield recurrence after #HIFU or #cryotherapy for #prostatecancer at therapy_focal in Washington, USA.

0 1 5 1K 0

View Details

Bryant_Lab @LabBryant

9 months ago

Tremendous news - well done @NHSBartsHealth !! Looking forward to further recruited participants in this key @NIHRresearch funded RCT of #focaltherapy versus radical treatment for #prostatecancer from @SITU_Oxford @OCTRUctu @QuinteTBristol @LabBryant

PART_Trial @PART_Trial

9 months ago

...and they're off! @NHSBartsHealth have recruited their 1st participant to the PART_Trial 🥳Congrats to all involved 👏 @LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

0 0 3 234 0

0 0 0 161 0

View Details

Bryant_Lab @LabBryant

9 months ago

Tremendous!! Many congratulations @MarkarSheraz Safe trip home, and it will be exciting to learn of your new collaborations and ideas for TransAtlantic Surgical Research!!!

Sheraz Markar @MarkarSheraz

9 months ago

Brilliant @AmCollSurgeons Congress in Chicago! So grateful to receive the international guest scholarship! Wonderful catching up with old and new friends. Brilliant to build stronger links between US UK for collaborative clinical trials. @NDSurgicalSci

4 3 25 2K 1

0 1 1 230 0

View Details

Bryant_Lab @LabBryant

9 months ago

@IP_London @LondonProstate1 @BloombergUK The @PART_Trial in the UK, an RCT funded by @NIHRresearch and led from @OCTRUctu and @SITU_Oxford , is actively recruiting patients with intermediate-risk prostate cancer to robustly evaluate #FocalTherapy vs #RadicalTherapy. Level 1 evidence is needed - and we will deliver it.

0 0 3 63 0

View Details

PART_Trial @PART_Trial

9 months ago

The seasons may be changing but there's lots to celebrate - as #PART has just recruited it's 110th participant thanks to the @OUHospitals team 🥳@LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

0 2 4 399 0

View Details

PART_Trial @PART_Trial

10 months ago

We've recently welcomed @nhsuhcw to #PART and they have already recruited their 1⃣st participant‼️Well done to all 🥳👏@LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

0 2 5 273 0

View Details

Bryant_Lab @LabBryant

10 months ago

Thrilled to have been awarded full Professor of Urology at @NDSurgicalSci at @UniofOxford Huge thank you to all who have supported me - starting at @BryntegSixth to @sheffielduni then @UniofOxford - & especially @Freddie_Hamdy & my family & colleagues. #prostatecancer #research

18 2 44 2K 0

View Details

Bryant_Lab @LabBryant

10 months ago

@sciqst @PART_Trial @NIHRresearch @SITU_Oxford @QuinteTBristol @OCTRUctu Thank you Dr Di Giacomo; @PART_Trial will assess oncological efficacy as #1 outcome; important #2 outcomes include side effects / treatment toxicity, QOL, health economics. No planned interim analyses. We plan to submit the protocol for publication soon, so please 👀

0 0 1 34 0

View Details

Bryant_Lab @LabBryant

10 months ago

A big day for the @PART_Trial 100 recruited participants, a significant way towards our required sample size, with the aim of delivering level 1 evidence for #focaltherapy versus #radicaltreatment for #prostatecancer @NIHRresearch @SITU_Oxford @QuinteTBristol @OCTRUctu

PART_Trial @PART_Trial

10 months ago

We did it!! #PART has recruited its 1⃣0⃣0⃣th participant at @FrimleyHealth 🥳 a massive thank you and to all our #PARTsites for your hard work getting us there!!!👏we are a step closer to answering our important question 👍@LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

0 3 7 1K 0

1 1 2 793 0

View Details

Bryant_Lab @LabBryant

11 months ago

@Lara__Rodriguez @LondonProstate1 @SIU_Journal @FocalSociety @IMMontsouris Nice review - but no mention of the fact there are several important ongoing RCTs recruiting patients with #prostatecancer comparing #focaltherapy vs radical treatment e.g. FARP, PRIS and @PART_Trial - to provide level 1 evidence.

0 0 0 52 0

View Details

Bryant_Lab @LabBryant

11 months ago

@CardiffCityFC Unreasonable for @CardiffCityFC to make it mandatory to have bought a Port Vale ticket for 2025-26 (which I can’t get to) to be eligible for Luton away; I went to over a dozen away last season and have a season ticket.